Eight (8) abstracts will be selected by a screening committee for platform presentation during the Walsh in Asia session in the ASNOS 2019 congress. Abstracts that are not selected for inclusion in the Walsh in Asia session will be offered the opportunity to present as a poster presentation during the congress.
The presenting author must be a registered participant for the ASNOS 2019 Congress.
WALSH IN ASIA ABSTRACT SUBMISSION GUIDELINES:
The Walsh in Asia Session, named after Dr. Frank B. Walsh, will comprise of short clinical case presentation and discussion of neuro-ophthalmology cases (adult or pediatric) that are interesting, unusual, and informative. The diagnosis should be supported by appropriate pathologic material, bacteriologic cultures, laboratory analysis, genetic testing, neuro-imaging tests, etc.
All abstracts should be submitted online.
Abstracts must be in English.
The title should not reveal the diagnosis but should be relevant to the case material.
Six items are needed for submission of a Walsh in Asia case:
Summary of clinical history & exam findings (not more than 300 words);
Case abstract with references (not more than 300 words)
Case Dilemmas – e.g. difficult decision making, incorrect diagnoses (not more than 75 words);
Two/Three teaching points;
Representative Radiology Images (not more than 10 images; however, additional images, including full imaging discs, may be required for review);
Representative Pathology Images (not more than 10 images; however, additional images, including glass pathology slides, may be required for review)
Please crop out any patient identifiers in any images you upload.
Based on the pathologist’s review, glass pathology slides may be requested.
Based on the radiologist’s review, full imaging discs may be requested.
Please check this page regularly for more updates on Walsh in Asia submission guidelines. Submission gateway is not yet open. Abstract submission will open sometime in the 3rd quarter of 2019. To know more about submission date deadlines please click here.